Open-label, Long-term Safety Study of Avoralstat in Subjects With Hereditary Angioedema
Clinical trial NCT02670720 · TERMINATED
Trial details
- NCT number
- NCT02670720
- Sponsor
- BioCryst Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-01
- Primary completion
- 2016-02-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.